Mirum Pharmaceuticals, Inc. MIRM Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$798.84M-3,319% | -$23.36M+43.6% | -$41.42M+29.3% | -$58.56M+24.3% | -$77.34M+12.1% | ||
| $25.07M+3.4% | $24.24M+0.1% | $24.23M0.0% | $24.22M+0.8% | $24.02M+1.6% | ||
| $91.82M+28.6% | $71.42M+8.8% | $65.65M+10.5% | $59.43M+12.6% | $52.8M+9.0% | ||
| -$170.98M-406% | $55.83M— | —— | —— | —— | ||
| $1.58M+65.3% | $954K+155% | $374K+1.6% | $368K-64.0% | $1.02M+2.8% | ||
| -$20.4M+18.3% | -$24.96M0.0% | -$24.96M+38.8% | -$40.77M+61.9% | -$106.89M-17.8% | ||
| $303.86M+657% | $40.14M+10.0% | $36.48M+50.4% | $24.25M+6.1% | $22.85M+29.1% | ||
| $114.39M+52.0% | $75.24M+27.3% | $59.11M+1,308% | -$4.89M+94.6% | -$90.6M-42.9% | ||
| -$172.55M-414% | $54.87M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Mirum Pharmaceuticals, Inc. generate?
- Mirum Pharmaceuticals, Inc. (MIRM) generated -$171.0M in operating cash flow over the trailing twelve months.
- What is Mirum Pharmaceuticals, Inc.'s free cash flow?
- After $1.6M of capital expenditures, Mirum Pharmaceuticals, Inc.'s free cash flow was -$172.6M over the trailing twelve months, down 45270.7% year over year.
- Where does Mirum Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Mirum Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
